Joinn Laboratories Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
2,649
- Stock Symbol
-
603127
- Investments
-
6
- Share Price
-
$4.83
- (As of Friday Closing)
Joinn Laboratories General Information
Description
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
Contact Information
Website
www.joinnlabs.comCorporate Office
- No. 5, Rongjing East Street
- Beijing Economic and Technological Development Area
- Beijing, 100176
- China
Corporate Office
- No. 5, Rongjing East Street
- Beijing Economic and Technological Development Area
- Beijing, 100176
- China
Joinn Laboratories Stock Performance
As of 20-Nov-2026, Joinn Laboratories’s stock price is $4.83. Its current market cap is $3.31B with 749M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.83 | $5.29 | $3.78 - $8.24 | $3.31B | 749M | 35.5M | $0.22 |
Joinn Laboratories Financials Summary
As of 30-Sep-2026, Joinn Laboratories has a trailing 12-month revenue of $270M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,752,304 | 3,118,787 | 1,145,456 | 1,870,251 |
| Revenue | 269,934 | 230,503 | 281,283 | 335,905 |
| EBITDA | 171,677 | 56,325 | 18,616 | 70,263 |
| Net Income | 166,382 | 41,417 | 10,323 | 56,113 |
| Total Assets | 1,692,770 | 1,383,782 | 1,287,127 | 1,414,547 |
| Total Debt | 5,533 | 3,086 | 8,352 | 9,794 |
Joinn Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Joinn Laboratories Signals
Joinn Laboratories Investments & Acquisitions (6)
Joinn Laboratories’s most recent deal was a Merger/Acquisition with Yingmao Biotechnology. The deal was made on 29-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yingmao Biotechnology | 29-Apr-2022 | Merger/Acquisition | Animal Husbandry | ||
| Weimei Biotechnology | 01-Apr-2022 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Yinmore Group | 01-Jan-2022 | Merger/Acquisition | Conglomerates | ||
| JOINN Biologics | 31-Aug-2021 | Early Stage VC | Other Pharmaceuticals and Biotechnology | ||
| Biomere | 10-Dec-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Joinn Laboratories ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
21.19 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Joinn Laboratories Exits (2)
Joinn Laboratories’s most recent exit was on 29-Apr-2022 from Yingmao Biotechnology. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Yingmao Biotechnology | 29-Apr-2022 | Completed |
|
||
| Weimei Biotechnology | 01-Apr-2022 | Merger/Acquisition | Completed |
Joinn Laboratories Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Yinmore Group | Kunming, China | 1997 | |
| Biomere | Worcester, MA | 1996 |
Joinn Laboratories FAQs
-
When was Joinn Laboratories founded?
Joinn Laboratories was founded in 1995.
-
Where is Joinn Laboratories headquartered?
Joinn Laboratories is headquartered in Beijing, China.
-
What is the size of Joinn Laboratories?
Joinn Laboratories has 2,649 total employees.
-
What industry is Joinn Laboratories in?
Joinn Laboratories’s primary industry is Laboratory Services (Healthcare).
-
Is Joinn Laboratories a private or public company?
Joinn Laboratories is a Public company.
-
What is Joinn Laboratories’s stock symbol?
The ticker symbol for Joinn Laboratories is 603127.
-
What is the current stock price of Joinn Laboratories?
As of 20-Nov-2026 the stock price of Joinn Laboratories is $4.83.
-
What is the current market cap of Joinn Laboratories?
The current market capitalization of Joinn Laboratories is $3.31B.
-
What is Joinn Laboratories’s current revenue?
The trailing twelve month revenue for Joinn Laboratories is $270M.
-
What is Joinn Laboratories’s annual earnings per share (EPS)?
Joinn Laboratories’s EPS for 12 months was $0.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process